Abstract
Osteomyelitis is an infection of bone and bone marrow. It is attributed to several factors: antibiotic short half-life, poor blood circulation at the infected area, and systemic antibiotic toxicity usage of the required high systemic dose. All evocating osteomyelitis presents an additional challenge, because the infecting bacteria form a biofilm mode of growth, which, on devascularized surfaces, shields them from antibiotics. Widespread research is currently being conducted on local drug delivery systems to treat osteomyelitis. By utilizing newer forms of sustained-release antibiotic delivery systems, it will be possible to deliver such antibiotics at constant rates over a prolonged period of time and eliminate the need for multiple dosing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schmidmaier G, Lucke M, Wildemann B, Haas NP, Raschke M (2006) Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury 37(Suppl 2):S105–S112
Cierny G III, Mader JT, Penninck JJ (2003) A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res (414): 7–24
Lew DP, Waldvogel FA (1997) Osteomyelitis. New Engl J Med 336(14):999–1007
Gold RH, Hawkins RA, Katz RD (1991) Bacterial osteomyelitis: findings on plain radiography, CT, MR, and scintigraphy. AJR Am J Roentgenol 157(2):365–370
Santiago Restrepo C, Gimenez CR, McCarthy K (2003) Imaging of osteomyelitis and musculoskeletal soft tissue infections: current concepts. Rheum Dis Clin North Am 29(1):89–109
Tumeh SS, Aliabadi P, Weissman BN, McNeil BJ (1987) Disease activity in osteomyelitis: role of radiography. Radiology 165(3):781–784
Termaat MF, Raijmakers PG, Scholten HJ, Bakker FC, Patka P, Haarman HJ (2005) The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis. J Bone Joint Surg Am 87(11):2464–2471
Hartmann A, Eid K, Dora C, Trentz O, von Schulthess GK, Stumpe KD (2007) Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis. Eur J Nucl Med Mol Imaging 34(5):704–714
Palestro CJ, Torres MA (1997) Radionuclide imaging in orthopedic infections. Semin Nucl Med 27(4):334–345
Mackowiak PA, Jones SR, Smith JW (1978) Diagnostic value of sinus-tract cultures in chronic osteomyelitis. JAMA 239(26):2772–2775
Kaplan SL (2005) Osteomyelitis in children. Infect Dis Clin North Am 19(4):787–797, vii
Prasarn ML, Ahn J, Achor T, Matuszewski P, Lorich DG, Helfet DL (2009) Management of infected femoral nonunions with a single-staged protocol utilizing internal fixation. Injury 40(11):1220–1225
Key JA (2009) The classic: sulfonamides in the treatment of chronic osteomyelitis. 1944. Clin Orthop Relat Res 467(7):1662–1669
Mouzopoulos G, Kanakaris NK, Kontakis G, Obakponovwe O, Townsend R, Giannoudis PV (2011) Management of bone infections in adults: the surgeon’s and microbiologist’s perspectives. Injury 42(Suppl 5):S18–S23
Sheehy SH, Atkins BA, Bejon P, Byren I, Wyllie D, Athanasou NA, Berendt AR, McNally MA (2010) The microbiology of chronic osteomyelitis: prevalence of resistance to common empirical anti-microbial regimens. J Infect 60(5):338–343
Mader JT, Cripps MW, Calhoun JH (1999) Adult posttraumatic osteomyelitis of the tibia. Clin Orthop Relat Res (360): 14–21
Lew DP, Waldvogel FA (1995) Quinolones and osteomyelitis: state-of-the-art. Drugs 49(Suppl 2):100–111
Isefuku S, Joyner CJ, Simpson AH (2001) Toxic effect of rifampicin on human osteoblast-like cells. J Orthop Res 19(5):950–954
Holtom PD, Pavkovic SA, Bravos PD, Patzakis MJ, Shepherd LE, Frenkel B (2000) Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro. J Orthop Res 18(5):721–727
Galanakis N, Giamarellou H, Moussas T, Dounis E (1997) Chronic osteomyelitis caused by multi-resistant Gram-negative bacteria: evaluation of treatment with newer quinolones after prolonged follow-up. J Antimicrob Chemother 39(2):241–246
Allababidi S, Shah JC (1998) Kinetics and mechanism of release from glyceryl monostearate-based implants: evaluation of release in a gel simulating in vivo implantation. J Pharm Sci 87(6):738–744
Wang G, Liu SJ, Ueng SW, Chan EC (2004) The release of cefazolin and gentamicin from biodegradable PLA/PGA beads. Int J Pharm 273(1–2):203–212
Gursel I, Korkusuz F, Turesin F, Alaeddinoglu NG, Hasirci V (2001) In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. Biomaterials 22(1):73–80
Kanellakopoulou K, Giamarellos-Bourboulis EJ (2000) Carrier systems for the local delivery of antibiotics in bone infections. Drugs 59(6):1223–1232
Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M (2001) Biodegradable poly(D, L-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res 58(4):449–455
Menei P, Daniel V, Montero-Menei C, Brouillard M, Pouplard-Barthelaix A, Benoit JP (1993) Biodegradation and brain tissue reaction to poly(D, L-lactide-co-glycolide) microspheres. Biomaterials 14(6):470–478
Bostman O, Hirvensalo E, Makinen J, Rokkanen P (1990) Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers. J Bone Joint Surg Br 72(4):592–596
Price JS, Tencer AF, Arm DM, Bohach GA (1996) Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res 30(3):281–286
Ramchandani M, Robinson D (1998) In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. J Control Release 54(2):167–175
Baro M, Sanchez E, Delgado A, Perera A, Evora C (2002) In vitro-in vivo characterization of gentamicin bone implants. J Control Release 83(3):353–364
Benoit MA, Mousset B, Delloye C, Bouillet R, Gillard J (1997) Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections. Int Orthop 21(6):403–408
Zhang Z, Kuijer R, Bulstra SK, Grijpma DW, Feijen J (2006) The in vivo and in vitro degradation behavior of poly(trimethylene carbonate). Biomaterials 27(9):1741–1748
Neut D, Kluin OS, Crielaard BJ, van der Mei HC, Busscher HJ, Grijpma DW (2009) A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis. Acta Orthop 80(5):514–519
Van Leeuwen AC, Van Kooten TG, Grijpma DW, Bos RR (2012) In vivo behaviour of a biodegradable poly(trimethylene carbonate) barrier membrane: a histological study in rats. J Mater Sci Mater Med 23(8):1951–1959
Liao H, Walboomers XF, Habraken WJEM, Zhang Z, Li Y, Grijpma DW, Mikos AG, Wolke JGC, Jansen JA (2011) Injectable calcium phosphate cement with PLGA, gelatin and PTMC microspheres in a rabbit femoral defect. Acta Biomater 7(4):1752–1759
Kluin OS, van der Mei HC, Busscher HJ, Neut D (2009) A surface-eroding antibiotic delivery system based on poly-(trimethylene carbonate). Biomaterials 30(27):4738–4742
Le Ray AM, Chiffoleau S, Iooss P, Grimandi G, Gouyette A, Daculsi G, Merle C (2003) Vancomycin encapsulation in biodegradable poly(epsilon-caprolactone) microparticles for bone implantation. Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility. Biomaterials 24(3):443–449
Kim HW, Knowles JC, Kim HE (2004) Hydroxyapatite/poly(epsilon-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials 25(7–8):1279–1287
Lam CX, Hutmacher DW, Schantz JT, Woodruff MA, Teoh SH (2009) Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. J Biomed Mater Res A 90(3):906–919
Amsden BG, Tse MY, Turner ND, Knight DK, Pang SC (2006) In vivo degradation behavior of photo-cross-linked star-poly(epsilon-caprolactone-co-D, L-lactide) elastomers. Biomacromolecules 7(1):365–372
Tabata Y, Yamada K, Miyamoto S, Nagata I, Kikuchi H, Aoyama I, Tamura M, Ikada Y (1998) Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels. Biomaterials 19(7–9):807–815
Castro C, Evora C, Baro M, Soriano I, Sanchez E (2005) Two-month ciprofloxacin implants for multibacterial bone infections. Eur J Pharm Biopharm 60(3):401–406
Puga AM, Rey-Rico A, Magarinos B, Alvarez-Lorenzo C, Concheiro A (2012) Hot melt poly-epsilon-caprolactone/poloxamine implantable matrices for sustained delivery of ciprofloxacin. Acta Biomater 8(4):1507–1518
Jain JP, Modi S, Domb AJ, Kumar N (2005) Role of polyanhydrides as localized drug carriers. J Control Release 103:541–563
Jain JP, Chitkara D, Kumar N (2008) Polyanhydrides as localized drug delivery carrier: an update. Expert Opin Drug Deliv 5(8):889–907
Saito N, Takaoka K (2003) New synthetic biodegradable polymers as BMP carriers for bone tissue engineering. Biomaterials 24(13):2287–2293
Gunatillake PA, Adhikari R (2003) Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater 5:1–16, discussion 16
Li LC, Deng J, Stephens D (2002) Polyanhydride implant for antibiotic delivery–from the bench to the clinic. Adv Drug Deliv Rev 54(7):963–986
Laurencin CT, Gerhart T, Witschger P, Satcher R, Domb A, Rosenberg AE, Hanff P, Edsberg L, Hayes W, Langer R (1993) Bioerodible polyanhydrides for antibiotic drug delivery: in vivo osteomyelitis treatment in a rat model system. J Orthop Res 11(2):256–262
Brin YS, Nyska A, Domb AJ, Golenser J, Mizrahi B, Nyska M (2009) Biocompatibility of a polymeric implant for the treatment of osteomyelitis. J Biomater Sci Polym Ed 20(7–8):1081–1090
Brin YS, Golenser J, Mizrahi B, Maoz G, Domb AJ, Peddada S, Tuvia S, Nyska A, Nyska M (2008) Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin. J Control Release 131(2):121–127
Krasko MY, Golenser J, Nyska A, Nyska M, Brin YS, Domb AJ (2007) Gentamicin extended release from an injectable polymeric implant. J Control Release 117(1):90–96
Shikanov A, Vaisman B, Krasko MY, Nyska A, Domb AJ (2004) Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity. J Biomed Mater Res A 69(1):47–54
Du J, Jasti B, Vasavada RC (1997) Controlled release of tobramycin sulfate from poly(ortho esters) implantable discs for the treatment of osteomyelitis. J Control Release 43(2–3):223–233
Knaepler H (2012) Local application of gentamicin-containing collagen implant in the prophylaxis and treatment of surgical site infection in orthopaedic surgery. Int J Surg 10(Suppl 1):S15–S20
Geiger M, Li RH, Friess W (2003) Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55(12):1613–1629
Riegels-Nielsen P, Espersen F, Holmich LR, Frimodt-Moller N (1995) Collagen with gentamicin for prophylaxis of postoperative infection. Staphylococcus aureus osteomyelitis studied in rabbits. Acta Orthop Scand 66(1):69–72
Zhou J, Fang T, Wang Y, Dong J (2012) The controlled release of vancomycin in gelatin/beta-TCP composite scaffolds. J Biomed Mater Res A 100(9):2295–2301
Di Silvio L, Bonfield W (1999) Biodegradable drug delivery system for the treatment of bone infection and repair. J Mater Sci Mater Med 10(10/11):653–658
George M, Abraham TE (2006) Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan—a review. J Control Release 114:1–14
Yenice I, Calis S, Kas H, Ozalp M, Ekizoglu M, Hincal A (2002) Biodegradable implantable teicoplanin beads for the treatment of bone infections. Int J Pharm 242(1–2):271–275
Yenice I, Calis S, Atilla B, Kas HS, Ozalp M, Ekizoglu M, Bilgili H, Hincal AA (2003) In vitro/in vivo evaluation of the efficiency of teicoplanin-loaded biodegradable microparticles formulated for implantation to infected bone defects. J Microencapsul 20(6):705–717
Khor E, Lim LY (2003) Implantable applications of chitin and chitosan. Biomaterials 24:2339–2349
Higuchi T (1963) Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–1149
Cevher E, Orhan Z, Mulazimoglu L, Sensoy D, Alper M, Yildiz A, Ozsoy Y (2006) Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres. Int J Pharm 317(2):127–135
Turesin F, Gursel I, Hasirci V (2001) Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release. J Biomater Sci Polym Ed 12(2):195–207
Yates CC, Whaley D, Babu R, Zhang J, Krishna P, Beckman E, Pasculle AW, Wells A (2007) The effect of multifunctional polymer-based gels on wound healing in full thickness bacteria-contaminated mouse skin wound models. Biomaterials 28(27):3977–3986
Elsner JJ, Berdicevsky I, Zilberman M (2011) In vitro microbial inhibition and cellular response to novel biodegradable composite wound dressings with controlled release of antibiotics. Acta Biomater 7(1):325–336
Kimakhe S, Bohic S, Larrose C, Reynaud A, Pilet P, Giumelli B, Heymann D, Daculsi G (1999) Biological activities of sustained polymyxin B release from calcium phosphate biomaterial prepared by dynamic compaction: an in vitro study. J Biomed Mater Res 47(1):18–27
Peltier LF, Jones RH (2004) Treatment of unicameral bone cysts by curettage and packing with plaster-of-Paris pellets. 1978. Clin Orthop Relat Res (422): 145–147
Calhoun JH, Manring MM, Shirtliff M (2009) Osteomyelitis of the long bones. Semin Plast Surg 23(2):59–72
Scharer BM, Sanicola SM (2009) The in vitro elution characteristics of vancomycin from calcium phosphate-calcium sulfate beads. J Foot Ankle Surg 48(5):540–542
Beardmore AA, Brooks DE, Wenke JC, Thomas DB (2005) Effectiveness of local antibiotic delivery with an osteoinductive and osteoconductive bone-graft substitute. J Bone Joint Surg Am 87(1):107–112
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Controlled Release Society
About this chapter
Cite this chapter
Khan, W., Challa, V.G.S., Pawar, R.P., Nyska, M., Brin, Y.S., Domb, A.J. (2014). Antibiotics Delivery for Treating Bone Infections. In: Domb, A., Khan, W. (eds) Focal Controlled Drug Delivery. Advances in Delivery Science and Technology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-9434-8_21
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9434-8_21
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-9433-1
Online ISBN: 978-1-4614-9434-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)